Kathleen Sebelius
CIK 1654316 · last filed 2026-06-12
Kathleen Sebelius is a corporate insider who has filed 34 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for HUMAW, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$132.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $39.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$39.3K
4
34
$132.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HUMAW | Director | 148,025 | $0.01 | $1.3K | $88.0K | 10 | 2026-06-12 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 32,671 | $104.91 | $3.43M | $0 | 9 | 2024-12-20 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | 100 | $26.98 | $2.7K | $44.8K | 6 | 2020-09-17 |
| DERM | Director | 6,000 | $6.32 | $37.9K | $0 | 6 | 2019-06-14 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | HUMAW | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | HUMAW | Buy (P) | +56,818 | $50.0K | EDGAR |
| 2025-07-16 | EXACT SCIENCES CORP (EXAS) Delisted | Notice (144) | −8,164 | -$433.6K | EDGAR |
| 2025-06-16 | HUMAW | Grant (A) | — | $0 | EDGAR |
| 2025-04-08 | HUMAW | Buy (P) | +50,000 | $66.0K | EDGAR |
| 2024-12-20 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +7,672 | $0 | EDGAR |
| 2024-09-11 | HUMAW | Mixed | +1,818 | -$78 | EDGAR |
| 2024-09-10 | HUMA | Notice (144) | −5,182 | -$28.0K | EDGAR |
| 2024-06-17 | HUMAW | Mixed | +39,389 | $100.8K | EDGAR |
| 2024-06-17 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +6,889 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.